Delveinsight

FEBRUARY 18, 2021

Like troops at the forefront of any battle, our immune system continually marches to protect us from foreign elements and invaders, including bacteria, viruses, and others. During the whole process, Fibrinogen, the most abundant protein of the blood plasma after albumin and immunoglobulins, gets converted into insoluble protein fibrin.

Marketing 52

Marketing Protein Bacteria Pharma Companies 52

pharmaphorum

SEPTEMBER 28, 2021

VLA15 targets the outer surface protein A (OspA) of the Borrelia burgdorferi bacteria that causes Lyme disease, a tick-borne infection that causes a characteristic rash that can be accompanied by flu-like symptoms and – in some cases – debilitating tiredness and aches that can last for years.

Vaccine 105

Vaccine Vaccination Bacteria Protein 105

pharmaphorum

JUNE 20, 2022

The deal gives Valneva a cash injection that it will be able to use to advance Lyme disease candidate VLA15 towards the market, but the revised licensing terms means that the French biotech will shoulder more of the financial cost of the development programme. Pfizer has acquired an 8.1%

Vaccine 98

Vaccine Vaccination Licensing Licensing 98

pharmaphorum

AUGUST 7, 2020

Biogen has bought a licence to co-develop and co-market potential Parkinson’s disease drugs with US biotech Denali, in a deal worth more than $2.1 Biogen and Denali will co-market the lead LRRK2 product in the US and China, and Biogen will commercialise in all other markets.

Bacteria 69

Bacteria Marketing Licensing Licensing 69

XTalks

AUGUST 26, 2024

A recent study published in the journal Nutrients highlights significant concerns, revealing that many baby foods contain excessive amounts of sugar and salt, coupled with misleading marketing claims. The study examined 651 baby food products from ten major US supermarkets, focusing on foods marketed for children aged six to 36 months.

Containment 52

Containment Production Regulation Protein 52

Pharmaceutical Technology

MARCH 24, 2023

TB is caused by the bacillus Mycobacterium tuberculosis and is transmitted when infected individuals expel bacteria into the air (e.g., Fox says adjuvant protein subunit vaccines can be a safer approach compared to live attenuated virus vaccines as there is a minimized risk of developing side effects. by coughing).

Vaccine 162

Vaccine Vaccination Clinical Trials Trials 162

Roots Analysis

FEBRUARY 27, 2024

The firm also has the right to obtain exclusive licenses to the Affimer proteins for clinical development and commercialization. What are Affimers : Affimers are small proteins that target and bind molecules on cellular surfaces in a manner analogous to monoclonal antibodies.

Antibody 52

Antibody Licensing Licensing Contract Manufacturing 52

pharmaphorum

MAY 31, 2022

billion takeover of US biotech Affinivax, buying a pneumococcal vaccine candidate that is aiming to break into a market that for years has been dominated by Pfizer’s Prevnar franchise. GlaxoSmithKline has agreed a $3.3 GSK said it is paying $2.1 billion upfront for Cambridge, Massachusetts-based Affinivax, with another $1.2

Vaccine 52

Vaccine Vaccination Bacterium Sales 52

pharmaphorum

APRIL 26, 2022

Starting phase 3 testing of VLA15 will trigger another milestone payment from Pfizer, which paid $130 million upfront in 2020, with another $35 million due in development milestones and $143 million in early commercialisation payments if the shot reaches the market.

Vaccine 69

Vaccine Vaccination Bacteria Trials 69

pharmaphorum

JULY 14, 2021

Last year, Pfizer made almost $6 billion from its Prevnar 13 vaccine, which covers 13 common serotypes of Streptococcus pneumoniae – a bacteria which causes non-invasive illnesses like pneumonia, sinusitis and middle ear infections, as well as invasive diseases like meningitis. That is equivalent to 14% of Pfizer’s total revenues.

Immune Response 52

Immune Response Vaccine Vaccination Protein 52

Roots Analysis

JANUARY 14, 2024

Biologics activate certain proteins or cells in your immune system to create specific responses to targets, while many conventional systemic drugs activate the entire immune system in a more generalized manner. Insect cell lines have been frequently used as recombinant protein expression systems. cerevisiae) and Pichia pastoris.

Contract Manufacturing 40

Contract Manufacturing Protein Manufacturing Production 40

Roots Analysis

OCTOBER 16, 2023

Biopharmaceutical filtration is a critical step in the production of biopharmaceuticals, including proteins, antibodies, and vaccines. Membrane Filters: Membrane filters are typically used for sterilization and removal of smaller impurities such as bacteria and viruses. are used to remove any residual bacteria, viruses, or endotoxins.

Bacteria 40

Bacteria Production Protein Contamination 40

The Pharma Data

APRIL 26, 2022

This investigational multivalent protein subunit vaccine uses an established mechanism of action for a Lyme disease vaccine that targets the outer surface protein A (OspA) of Borrelia burgdorferi, the bacteria that cause Lyme disease. About VLA15 VLA15 is the only Lyme disease vaccine candidate currently in clinical development.

Vaccine 52

Vaccine Vaccination Bacteria Protein 52

XTalks

FEBRUARY 4, 2021

The air of a hospital is not so clean and contains bacteria.”. Dr. Durand explains that the bacteria-laden air can cause bacteria to be deposited in the lungs, leading to pneumonia and then sepsis. For sepsis, a commercial immunoassay pancreatic stone protein (PSP) test is utilized.

Allergies 98

Allergies Bacteria Development Containment 98

Pfizer

FEBRUARY 16, 2023

Food and Drug Administration (FDA) and Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) in 2025, pending successful completion of the Phase 3 studies and subject to the agreement of these regulatory agencies to proposed modifications of the clinical trial plan. FDA in July 2017.

Clinical Trials 76

Clinical Trials Clinical Trials Vaccine Vaccination 76

The Pharma Data

JULY 21, 2021

This investigational multivalent protein subunit vaccine uses an established mechanism of action for a Lyme disease vaccine that targets the outer surface protein A (OspA) of Borrelia burgdorferi , the bacteria that cause Lyme disease. About Lyme Disease. According to the U.S.

Vaccine 52

Vaccine Vaccination Trials Bacteria 52

Pharmaceutical Technology

MAY 17, 2023

In addition to revolutionising diabetes care, insulin has become an essential component of biopharmaceutical manufacturing, where its growth-supplementing ­­­properties are relied on to enhance commercially available cell culture media and achieve higher yields of target therapeutic proteins.

Insulin 130

Insulin Production Manufacturing Contamination 130

XTalks

JUNE 2, 2023

California-based Olli Salumeria , known for its high-quality, artisanal salami, recently made a groundbreaking announcement: it’s launching the first preservative-free salami in the North American market. According to Research and Markets , the global clean label ingredients market is expected to reach $32.08

Production 52

Production Bacteria Marketing Containment 52

Roots Analysis

OCTOBER 16, 2023

Once isolated, molecular clones can be used to generate multiple copies of DNA for the analysis of gene sequences and / or to express proteins obtained for the study or utilization of protein function. These clones can be manipulated and mutated in vitro to alter the expression and function of a protein.

DNA 40

DNA Gene Protein In-Vitro 40

The Pharma Data

APRIL 22, 2023

Plasma cells produce antibodies that protect the body from invasive foreign substances, such as bacteria and viruses. When transforming into cancerous myeloma cells, however, plasma cells continue to produce monoclonal immunoglobulin (M protein) that is not capable of attacking the foreign substances.

Antibody 40

Antibody Protein Bacteria Drugs 40

XTalks

DECEMBER 22, 2021

RNA, and its protein-generating form messenger RNA (mRNA) discovered in 1961 , has quickly transitioned from being an obscure, finicky molecule that is difficult to work with, to becoming a significant cornerstone of therapeutic innovation in pharma and biotech. The RNA Revolution: From mRNA Vaccines to RNA Editing. Wearable Technology.

Life Science 98

Life Science RNA Vaccine Vaccination 98

pharmaphorum

OCTOBER 27, 2021

There was bad news for Lilly elsewhere is its Alzheimer’s pipeline as it announced the demise of anti-tau protein antibody zagotenemab, which had reached phase 2 but failed to have an impact on its primary endpoint. Cortexyme trial disappoints.

Trials 52

Trials Drugs Sales Bacteria 52

The Pharma Data

OCTOBER 14, 2020

The highly potent and selective payload series represents a powerful new class within ADC development with novel protein alkylating cytotoxicity. The funds will be used to bring Ori’s innovative manufacturing platform to the market. CARB-X will provide Polyphor with initial funding of up to $2.62 Source link.

Clinical Trials 52

Clinical Trials Clinical Trials Manufacturing In-Vivo 52

The Pharma Data

OCTOBER 26, 2020

AR-711 exhibits high affinity for SARS-CoV-2 spike protein, approximately 10-fold or higher than mAb candidates currently in late stage clinical testing. AR-701 is a cocktail of fully human mAbs discovered from convalescent COVID-19 patients that are directed at multiple envelope proteins of the SARS-CoV-2 virus. AR-701 (COVID-19).

Antibody 52

Antibody Genetic Engineering Development Clinical Trials 52

The Pharma Data

OCTOBER 19, 2020

The company’s suite of market-leading molecular profiling offerings assesses DNA, RNA and proteins to reveal a molecular blueprint that helps physicians and cancer patients make more precise and personalized treatment decisions. Europe , Asia and other international markets. Caris provides services throughout the U.S.,

Life Science 52

Life Science Clinical Trials Clinical Trials RNA 52

XTalks

DECEMBER 17, 2021

While researchers are still learning more about Omicron, what we know is that it has the ability to spread quickly, has over 30 mutations in its spike protein and can impact the effectiveness of current vaccines. The global neuromodulation market is currently valued at $5.8 billion and is expected to grow to $8.8

Life Science 98

Life Science Vaccine Vaccination Trials 98

XTalks

AUGUST 2, 2023

Join us as we present an in-depth analysis of each company’s revenue, net income, R&D investments, core therapeutic areas, market presence and strategic collaborations. is a global pharmaceutical company, working across both developed and emerging markets. 2022 Revenue: Pfizer reported an annual revenue of $100.33 Pfizer Inc.

Sales 98

Sales Manufacturing FDA Approval Life Science 98

The Pharma Data

OCTOBER 19, 2020

There are more than 90 different types of pneumococcal bacteria which can affect adults differently than children. The global prevalence of pneumococcal disease, an infection caused by bacteria called Streptococcus pneumoniae , is evolving. Plans for global regulatory licensure applications, beginning with the U.S.

Vaccine 52

Vaccine Vaccination Immune Response Containment 52

The Pharma Data

JUNE 18, 2021

PREVNAR 20 includes capsular polysaccharide conjugates for the 13 serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F) already included in Prevnar 13 ® (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM 197 Protein]). Global President of Pfizer Vaccines. “We About 20-Valent Pneumococcal Conjugate Vaccine Regulatory Review.

Vaccine 52

Vaccine Vaccination FDA Approval Containment 52

The Pharma Data

DECEMBER 15, 2020

Scientists will be testing a drug class targeting the C-reactive protein (CRP) marker of acute inflammation in the body. The protein may be involved in such conditions, and a CRP test may be used to find or monitor conditions that cause inflammation. These include inflammatory bowel disease, lupus or rheumatoid arthritis.

Clinical Trials 52

Clinical Trials Clinical Trials Antibody Trials 52

Delveinsight

DECEMBER 2, 2020

As of now, there is no cure for Rheumatoid Arthritis; however, medication and supportive treatments options are available in the market that can manage its progression. As per the Delveinsight, the total prevalent cases of Rheumatoid Arthritis in the seven major markets (i.e Similarly, as per the study conducted by Alan J.

Marketing 60

Marketing Hormones Antibody Development 60

XTalks

DECEMBER 24, 2020

SARS-CoV-2 is characterized by an outer surface speckled with spike proteins, giving it a crown-like appearance, hence the name “corona,” which is the Latin word for crown. The spike protein is critical for binding to ACE2 receptors on host cells — this interaction mediates the entry of the virus into cells.

Life Science 111

Life Science Vaccine Vaccination Gene 111

Roots Analysis

JANUARY 27, 2025

Protein therapeutics have completely revolutionized the healthcare segment, greatly influencing the study and treatment of human diseases by conferring precise targeting ability to therapeutic modalities. Considering their vast potential, close to 50% of the top selling drugs in 2023 were protein therapeutics.

Protein 40

Protein Reagent Marketing Gene 40

The Pharma Data

MAY 14, 2021

Charles River loses a battle over harvesting horseshoe crabs used for testing bacteria in drugs ( STAT ). After going down different drug discovery paths, Genentech vets reunite at Foresite Labs to map the ‘protein interactome’ ( Endpoints ). In Focus: International. Medtech.

Gene Therapy 52

Gene Therapy Gene Vaccine Vaccination 52